Product Information
GABAPENTIN 600 MG TABLET is a generic product labeled by Mullan Pharmaceutical Inc., priced at $0.0668 per EA under NDC 83301000101. Its NADAC has been published 46 times since Aug 13, 2025.
Strength
600 mg/1
Manufacturer
Mullan Pharmaceutical Inc.NDC
83301000101
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA207057On Market Since
1/1/2024
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 600 MG TABLET has been published 46 times since Aug 13, 2025, and over the history we have for it it has declined 12.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0668 per EA |
|---|---|
| All-time high | $0.0768 (Aug 13, 2025) |
| All-time low | $0.0668 (Jun 17, 2026) |
| 52-week high | $0.0768 |
| 52-week low | $0.0668 |
| Median price | $0.0691 |
| Average price | $0.0702 |
| Largest weekly change | -2.9% (Oct 22, 2025) |
| Weeks tracked | 46 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 22 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 600 MG TABLET, manufactured by Mullan Pharmaceutical Inc., is $0.0668 per EA (NDC 83301000101), effective Jun 24, 2026.
How has the price of GABAPENTIN 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 600 MG TABLET has declined 12.9%. It has been tracked across 46 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 600 MG TABLET?
Since Aug 13, 2025, the NADAC for GABAPENTIN 600 MG TABLET has ranged from a low of $0.0668 (Jun 17, 2026) to a high of $0.0768 (Aug 13, 2025), with a median of $0.0691 per EA.
Are there cheaper alternatives to GABAPENTIN 600 MG TABLET?
22 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 600 MG TABLET, but none are currently priced below it.
Who manufactures GABAPENTIN 600 MG TABLET?
GABAPENTIN 600 MG TABLET (NDC 83301000101) is labeled by Mullan Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification